Stiris Research Inc

We are pleased to welcome Mo Hashi, who joins Stiris Research as Director of Business Development.

Mo brings extensive experience in the life sciences industry, with a focus on building client relationships, identifying new business opportunities, and supporting sponsors through the complex processes of clinical development.

We're glad to have him on the team and look forward to what we'll build together.

Welcome, Mo!

How do you design clinical trials in pan-tumor indications?

Basket trials represent a significant evolution in precision oncology, and biostatistics is what makes them possible. The following article explores the challenges and solutions behind these study designs.

In , a well-designed trial can still struggle in ex*****on: statistics integrated too late, feasibility visits that don't capture clinical reality, and multidisciplinary coordination that no one manages proactively.

We've learned that success depends on four non-negotiable principles:
➡️ Talk directly with sites before relying on questionnaires
➡️ Integrate statistics and operations from the design stage
➡️ Treat communication as the engine of the study, not as support
➡️ Build adaptability into the protocol, don't improvise during ex*****on

These aren't theories. They're what we find every time we ask the questions others don't.

Will you be at in Chicago? Carrie Hamilton, our Executive Director of Clinical Science, will be available to discuss study design, feasibility, and ex*****on in rare oncology.

Reach out to schedule a meeting 📩 [email protected]